Analytical Chemistry Platform Modalities Leader

Business Introduction
At GSK we have bold ambitions for patients aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines combining our understanding of the immune system with cutting-edge technology to transform peoples lives. GSK fosters a culture ambitious for patients accountable for impact and committed to doing the right thing making sure that we focus our efforts on accelerating significant assets that meet patients needs and have the highest probability of success.

Were uniting science technology and talent to get ahead of disease together.
Find out more:
Our approach to R&D

Position Summary

We are seeking a Platform Modalities Leader to provide enterpriselevel scientific leadership for the modernisation and evolution of Analytical Chemistry platforms supporting developing and complex therapeutic modalities.

This role owns the strategic expansion of analytical platform capability beyond the current smallmolecule portfolio enabling robust scalable and futureproof analysis of divalent small molecules drug conjugates including Warhead Linker Payloads for Antibody Drug Conjugates (WLPs for ADCs) and oligonucleotides.

The position plays a critical role in ensuring analytical platforms are positioned to meet both nearterm pipeline demands and longerterm modality evolution while maintaining the highest standards of scientific excellence.

The successful candidate will be a recognised authority who leads from the laboratory combining deep handson technical expertise with platformlevel strategic thinking. Through modernisation of existing capabilities introduction of new technologies and integration of highthroughput purification and analytical workflows this role will shape the future state of analytical platform delivery for emerging modalities.

This is a Scientific leader role G6 with 0 to 6 reports and will require extensive matrix leadership across chemistry modality informatics automation and technology organisations. Success will depend on the ability to influence direction set standards and deliver change across multiple reporting lines with impact at programme portfolio and organisational level. The role will require full-time on-site presence.

Key Responsibilities

Platform Strategy Ownership & Modernisation

• Provide endtoend scientific ownership of existing analytical and purification platforms at Stevenage and supporting small molecule and nextgeneration modalities including divalent small molecules WLPs and oligonucleotides.
• Define and drive platform strategy and modernisation ensuring analytical capabilities are scalable automationready and aligned to future modality and pipeline needs.
• Critically evaluate existing platforms and workflows setting direction for capability enhancement technology adoption and retirement where appropriate.
• Act as a key technical voice shaping capability roadmaps and investment priorities for analytical platforms.

Senior Scientific & Technical Leadership

• Lead from the laboratory on the most complex and highimpact analytical challenges providing authoritative input into method development troubleshooting and platform design.
• Serve as a recognised internal expert in platform analytics guiding experimental strategy data interpretation and riskbased decisionmaking.
• Set expectations for robustness reproducibility and data quality influencing best practice across analytical workflows and teams.

HighThroughput & Workflow Integration

• Drive the strategic integration of highthroughput purification and analytical workflows to enable efficient endtoend support of emerging modality pipelines.
• Provide scientific leadership at the interface of analysis bespoke purification informatics and automation to ensure platform coherence and longterm sustainability.
• Influence platform design choices to maximise throughput data quality and downstream usability.

Enterprise Collaboration & Influence

• Operate as a senior matrix leader partnering with Discovery Chemistry Modality teams Informatics Automation and external collaborators to align platform capabilities with business priorities.
• Communicate analytical platform strategy capability limitations and opportunity clearly to senior scientific and functional stakeholders.
• Translate complex technical capability into clear value propositions and guidance for project and portfoliolevel decisionmaking.

Governance Quality & Continuous Improvement

• Ensure analytical platforms meet high standards of quality safety and compliance consistent with organisational and regulatory expectations.
• Contribute to governance forums providing expert input into prioritisation risk assessment and investment decisions related to analytical platforms.
• Drive continuous improvement using dataled insight performance metrics and lessons learned across programmes and modalities.

Basic Qualifications & Skills

• BSc or equivalent in Chemistry Analytical Chemistry Pharmaceutical Sciences or a related discipline with at least 10 years of postgraduate experience in analytical chemistry.
• Deep demonstrable expertise in analytical platforms and associated analytical techniques relevant to modern drug modalities (e.g. LCMS HRMS advanced separations highthroughput and automated analysis).
• Proven experience modernising or transforming analytical platforms to support new modalities including at least one of bifunctional molecules oligonucleotides or WLPs for ADCs.
• Strong scientific judgement with the credibility to lead complex decisions from the laboratory through to platform strategy.
• Experience influencing and shaping highthroughput and automated analytical or purification solutions.
• Extensive experience of matrix leadership delivering outcomes through influence across multiple functions and reporting lines.
• Strong team player with excellent communication skills and the ability to engage challenge and influence senior scientific and functional leaders as evidenced by publication and/or external presentations.

Preferred Qualifications & Skills

• PhD in Analytical Chemistry Chemistry or a related discipline or MSc with significant and directly relevant experience.
• Handson experience supporting complex or emerging modalities such as divalent molecules WLPs and oligonucleotides.
• Experience shaping enterpriselevel platform strategy longterm capability roadmaps and/or capital investment proposals.
• Track record of delivering stepchange improvements through crossfunctional partnership spanning science informatics and technology.

This role will be based 100% on site.

How to apply
If this role speaks to you please apply your application use the cover letter or CV to describe how your experience meets the requirements. We encourage candidates from all backgrounds to apply.

Application close date - 11th June 2026

Why GSK

Uniting science technology and talent to get ahead of disease together.

GSK is a global biopharma company with a purpose to unite science technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade as a successful growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory immunology and inflammation; oncology; HIV; and infectious diseases to impact health at scale.

People and patients around the world count on the medicines and vaccines we make so were committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients accountable for impact and doing the right thing is the foundation for how together we deliver for patients shareholders and our people.

GSK is an Equal Opportunity Employer. This ensures that all qualified applicants will receive equal consideration for employment without regard to race color religion sex (including pregnancy gender identity and sexual orientation) parental status national origin age disability genetic information (including family medical history) military service or any basis prohibited under federal state or local law.

We believe in an agile working culture for all our roles. If flexibility is important to you we encourage you to explore with our hiring team what the opportunities are.

Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us at where you can also request a call.

Please note should your enquiry not relate to adjustments we will not be able to support you through these channels. However we have created a Recruitment FAQ guide. Click the link where you will find answers to multiple questions we receive

Important notice to Employment businesses/ Agencies

GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSKs commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.

Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license GSK may be required to capture and report expenses GSK incurs on your behalf in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSKs compliance to all federal and state US Transparency requirements. For more information please visit the Centers for Medicare and Medicaid Services (CMS) website at Experience:

IC